Showing results (31-40 of 661) with videos related to
Sort By:
Pageof 67
Experimental & Molecular Medicine|July 10, 2023
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategiesTaewan Kim, Carlo M CroceOncotarget|October 12, 2010
Is miR-29 an oncogene or tumor suppressor in CLL?Yuri Pekarsky, Carlo M CroceDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 13, 2013
MicroRNAs as therapeutic targets in chemoresistanceMichela Garofalo, Carlo M CroceCancer Letters|January 7, 2018
Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesisTaewan Kim, Carlo M CroceSeminars in Cancer Biology|January 10, 2021
MicroRNA and ER stress in cancerTaewan Kim, Carlo M CroceAdvances in Cancer Research|September 9, 2017
MicroRNAs and Cancer: A Long Story for Short RNAsAlessandra Drusco, Carlo M CroceCancer Research|August 3, 2005
Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiencyNicola Zanesi, Rita Mancini, Cinzia Sevignani, et al.Plos One|February 14, 2013
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancerLuciano Cascione, Pierluigi Gasparini, Francesca Lovat, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Regression of upper gastric cancer in mice by FHIT gene deliveryHideshi Ishii, Nicola Zanesi, Andrea Vecchione, et al.EMBO Molecular Medicine|February 22, 2012
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive reviewMarilena V Iorio, Carlo M CrocePageof 67